Christer Borgfeldt

Medicine and Dentistry

1. Woman 100%
2. Patient 61%
3. Ovarian Cancer 47%
4. Cervical Cancer 33%
5. Wart Virus 31%
6. Age 26%
7. Female Genital Tract Cancer 25%
8. Ovarian Tumor 23%
9. Surgery 21%
10. Cohort Analysis 18%
11. Follow up 18%
12. Cytotechnology 17%
13. Endometrial Cancer 16%
14. Cervical Screening 15%
15. Prognosis 12%
16. Disease 11%
17. CA-125 10%
18. Hospital 10%
19. Lymph Node Metastasis 10%
20. Therapeutic Procedure 10%
21. Relative Survival 9%
22. Lesion 9%
23. Biological Marker 8%
24. Cytoreductive Surgery 7%
25. Uterine Cervix Cytology 7%
26. Krukenberg Tumor 7%
27. Cancer 7%
28. Association 7%
29. Health Care Cost 7%
30. Endometriosis 7%
31. Minimally Invasive Surgery 6%
32. Liquid-Based Cytology 6%
33. Fertility 6%
34. Vulvar Cancer 6%
35. Symptom 6%
36. Lymph Node 6%
37. Triage 6%
38. Urokinase 5%
39. Ovarian Cyst 5%
40. Diagnostic Performance 5%
41. Urine 5%
42. Circulating Tumor DNA 5%
43. Predictive Factor 5%
44. Benign Tumor 5%
45. Mortality 5%
46. Overall Survival 5%
47. Squamous Cell Carcinoma 5%
48. Cervical Cancer Screening 5%
49. Activities of Daily Living 5%